A Credit Suisse analyst issued a broad new sector coverage for medical devices and related companies with strong Outperform ratings on Tuesday.
The top analyst upgrades, downgrades and initiations seen on Tuesday included Abbott Laboratories, Albermarle, Boston Scientific, BP, Embraer, Intuit, Marathon Oil and Norfolk Southern.
The top analyst upgrades, downgrades and initiations seen on Friday included Apple, Broadcom, Chesapeake Energy, Devon Energy, Lululemon Athletica, SecureWorks, Tesla and Zendesk.
The top analyst upgrades, downgrades and initiations seen on Tuesday included Adobe, Bank of America, Boston Scientific, Facebook, Las Vegas Sands, Merck, Tilray, TJX Companies and Valero Energy.
While these companies are better suited for accounts that have a higher risk tolerance, they all make good sense now, and all have outstanding upside potential.
While these four stocks are better suited for accounts that have a higher risk tolerance, they all make good sense now and all have outstanding upside potential.
Lee Jackson These 10 stocks received multiple analyst rating upgrades or price target hikes and also managed to have a gain for the week, even during the sell-off.
The top analyst upgrades, downgrades and other research calls from Friday include Alibaba, Alphabet, Amazon, Amgen, Apple, Mastercard, Nokia, Shopify and US Steel.
These five companies not only match up with the top Jefferies themes for this year, but they hit all the required metrics to be top picks for 2018.
The top analyst upgrades, downgrades and other research calls from Thursday include Alphabet, Avon, Bank of America, Intel, Roku, Snap and Western Digital.
These three red-hot companies continue to dominate their specific spheres of the medical technology world, and their stocks have had outstanding runs.
With the passage of tax reform looking almost certain, and with companies continuing to prove that all-time highs in the market will not hurt spending cash on share buybacks, the continuation of…
A new Jefferies research report focuses on the frm's new top growth picks, and we found four that may not only be great trades for the balance of 2017, but good stocks…
Despite the concerns over the struggles of politicians to craft a new health care plan for the United States, the health care sector, and many of its subsectors, have had an outstanding…
Not only do these top growth companies look poised for additional gains, they may have even more of a tailwind if the economy starts to pick up.
